Keyword | CPC | PCC | Volume | Score | Length of keyword |
---|---|---|---|---|---|
venetoclax cll | 0.89 | 0.3 | 8995 | 29 | 14 |
venetoclax | 0.9 | 0.7 | 3887 | 98 | 10 |
cll | 1.55 | 1 | 8576 | 50 | 3 |
Keyword | CPC | PCC | Volume | Score |
---|---|---|---|---|
venetoclax cll | 0.05 | 0.4 | 4944 | 29 |
venetoclax cll protocol | 1.31 | 0.4 | 6645 | 89 |
venetoclax cll fda | 0.1 | 0.8 | 9689 | 70 |
venetoclax cll side effects | 0.09 | 0.1 | 8029 | 10 |
venetoclax cll dosierung | 0.23 | 0.2 | 2227 | 75 |
venetoclax cll14 | 0.66 | 0.2 | 9030 | 35 |
venetoclax cll 11q | 0.42 | 0.9 | 3289 | 19 |
venetoclax cll nice | 0.64 | 1 | 4632 | 82 |
venetoclax cll ramp up | 1.92 | 0.5 | 2318 | 90 |
venetoclax cll approval | 1.45 | 1 | 244 | 20 |
venetoclax cll calendar | 0.66 | 1 | 8820 | 24 |
venetoclax cll indication | 1.43 | 1 | 7751 | 28 |
venetoclax cll fda approval | 0.94 | 0.4 | 3908 | 36 |
venetoclax cll package insert | 1.4 | 0.3 | 3661 | 48 |
venetoclax dosing schedule in cll | 0.09 | 0.8 | 1826 | 2 |
venetoclax dosing in cll | 0.81 | 0.5 | 6511 | 92 |
obinutuzumab venetoclax relapsed cll | 0.08 | 0.6 | 7527 | 24 |
gazyva and venetoclax for cll protocol | 0.38 | 0.5 | 2084 | 12 |
venetoclax treatment for cll | 1.39 | 0.9 | 8657 | 6 |
venetoclax mechanism of action cll | 0.77 | 1 | 8546 | 57 |
venetoclax obinutuzumab cll | 0.48 | 0.2 | 9231 | 93 |
venetoclax monotherapy cll | 0.13 | 0.5 | 2115 | 45 |